A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma
β Scribed by Wayne L. Furman, Lisa M. McGregor, M. Beth McCarville, Mihaela Onciu, Andrew M. Davidoff, Sandy Kovach, Dana Hawkins, Valerie McPherson, Peter J. Houghton, Catherine A. Billups, Jianrong Wu, Clinton F. Stewart, Victor M. Santana
- Book ID
- 113064568
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 353 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Highβgrade astrocytomas (HGA) carry a dismal prognosis and compose nearly 20% of all childhood brain tumors. The role of highβdose chemotherapy (HDCT) in the treatment of HGA remains unclear. ## METHODS In a nationwide study, The Children's Cancer Group (CCG) prospectiv
## Background: Chemotherapy is used as an alternative to irradiation or to minimize the irradiation exposure among infants with medulloblastoma or other cns embryonal tumors. adjuvant chemotherapy is commonly used in older children with high-risk medulloblastoma to improve survival or to allow a re